CClinicalTrials.gg
CompletedNCT05036304SAGEUpdated Jan 29, 2024

Supporting Aging Through Green Exercise (SAGE)

An interventional study of Aerobic Exercise Indoors and Aerobic Exercise Outdoors in Mild Cognitive Impairment and Aging, sponsored by University of British Columbia. Completed at 1 site in Canada. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-29.

Sponsored by University of British Columbia · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
65 Years to 80 Years
Sex
All
01

Study summary

Aerobic exercise is an evidence-based approach to mitigate cognitive decline in older adults with mild cognitive impairment (MCI). Emerging evidence suggests that the cognitive benefits of exercise may be enhanced when performed in outdoor, natural settings, as compared to indoor or built settings. Thus, the investigators aim to compare the effects of outdoor versus indoor walking programs on cognitive function among older adults with MCI. Secondary outcomes are motor function, emotional well-being, health-related behaviours, and quality of life. Participants will be randomly assigned to a 12--week, 3x/week program of either outdoor walking on forest trails or indoor walking on a treadmill. A 3-month followup will also be completed after trial completion.

Read the detailed description

Study Design: A 12-week, single-blinded, trial with two experimental arms. Participants will be randomized (1:1) to either outdoor walking (OP) or indoor walking or cycling (IP). Measurement will occur in person at baseline and at trial completion. Additionally, follow-up measurement of questionnaire-based outcomes will occur via email or phone at 3 months following trial completion. Outcome assessors will be trained by the research team and blinded to group allocation of the participants.

Participants: 68 community-dwelling adults aged 65-80 years old with probable MCI and in sufficient health to participate in aerobic exercise of moderate intensity

Interventional Arms: All participants will receive three group-based training sessions per week for 12 weeks, under the supervision of instructors with a relevant background and first aid certification. Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. For both OP and IP, aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of their heart rate reserve (HRR) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. OP participants will walk or jog a pre-determined route in trails of an urban forest (Pacific Spirit Park). IP participants will walk or jog on treadmills in the Exercise Prescription Suite of the Centre for Hip Health and Mobility (CHHM). Both OP and IP training groups will have a participant to instructor ratio of 3:1. To promote adherence to the exercise program, sessions will be offered at times that are convenient for each individual participant. Protocols will be adjusted as necessary to align with COVID-19 guidelines.

Measurement of descriptors and outcomes: Standardized protocols will be developed and study personnel will be trained. Assessors will be blinded to treatment allocation. We will measure descriptors and outcomes at baseline and at trial completion. Each measurement session will be 2 hours in duration. For these measurements, participants will complete a session of behavioural and clinical testing at the VCH Research Pavilion and the CHHM. To account for time-of-day effects, each participant's session start time will be the same at both timepoints, and the order of the assessments will be the same for all participants.

02

Conditions studied

  • Mild Cognitive Impairment
  • Aging

Keywords

  • green space
  • cognitive function
  • aerobic exercise
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's enrollment of 72 is above the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. achieve a score ≥18/30 and ≤24/30 on the Montreal Cognitive Assessment
  2. have subjective cognitive impairment based on interview
  3. have no significant impairment in daily function, as determined by a score ≥6/8 on the Lawton and Brody Instrumental Activities of Daily Living Scale
  4. no diagnosis of dementia
  5. aged 65 to 80 years old
  6. live independently in their own home
  7. live in the Greater Vancouver area
  8. read, write, and speak English with acceptable visual and auditory acuity
  9. are cleared to start a supervised exercise programme based on the Physical Activity Readiness Questionnaire for Everyone
  10. able to walk independently
  11. able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  1. participating in regular moderate to vigorous intensity aerobic exercise in the last 3 months
  2. planning to enroll in a concurrent exercise or drug trial targeting cognitive function
  3. diagnosed with a neurological, cerebrovascular, or psychiatric disease, or other chronic medical condition requiring intensive treatment and monitoring
  4. have major impairments in eyesight, hearing or motor movements
  5. have clinically significant neuropathy or musculoskeletal or joint disease
  6. have a recent traumatic brain injury, including concussions
  7. are currently using prescribed cognitive intervention or electromagnetic stimulation
  8. at the time of recruit, indicate they recently (within the last 2 months) or will start taking drugs that significantly alter cognition, movement, or affect, such as cholinesterase inhibitors, anticholinergics, hormone replacement therapy, or antidepressants
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
72 participants (actual)

Study arms

  • Active comparator
    Aerobic Exercise Indoors

    Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog on treadmills or cycle on stationary bikes in the Exercise Prescription Suite of the Centre for Hip Health and Mobility.

    Other: Aerobic Exercise Indoors

  • Experimental
    Aerobic Exercise Outdoors

    Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. participants will walk or jog pre-determined routes in trails of an urban forest (Pacific Spirit Park).

    Other: Aerobic Exercise Outdoors

Interventions

  • OtherAerobic Exercise Indoors

    Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog on treadmills or cycle on stationary bikes in the Exercise Prescription Suite of the Centre for Hip Health and Mobility.

  • OtherAerobic Exercise Outdoors

    Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog pre-determined routes in trails of an urban forest (Pacific Spirit Park)

06

What researchers measure

Primary outcomes

  1. Change in List Sorting Performance

    This is a measure of working memory

    Time frame: Baseline to 12 weeks

  2. Change in Digits Span Forwards and Backwards

    This is a measure of working memory.

    Time frame: Baseline to 12 weeks

Secondary outcomes

  1. Change in NIH Toolbox Cognitive Battery Performance

    Measures different cognitive domains, with a focus on executive functions

    Time frame: Baseline to 12 weeks

  2. Change in Digit Symbol Substitute Test

    A measure of processing speed and executive functions.

    Time frame: Baseline to 12 weeks

  3. Change in the Short Physical Performance Battery

    A measure of balance and mobility

    Time frame: Baseline to 12 weeks

  4. Change in Timed Up and Go Test

    A measure of general mobility

    Time frame: Baseline to 12 weeks

  5. Change in State-Trait Anxiety Inventory

    A measure of anxiety

    Time frame: Baseline to 12 weeks and 6 months

  6. Change in Centre for Epidemiological Studies Depression Scale

    A measure of depressive symptoms

    Time frame: Baseline to 12 weeks and 6 months

  7. Change in Blood Pressure

    Systolic and diastolic blood pressure

    Time frame: Baseline to 12 weeks

  8. Change in sensor measured sleep

    Using MotionWatch 8 to measure sleep quality

    Time frame: Baseline to 12 weeks

  9. Change in sensor measured physical activity

    Using MotionWatch 8 to measure levels and amount of physical activity

    Time frame: Baseline to 12 weeks

  10. Change in Physical Activity Scale for the Elderly

    A self-report measure of physical activity, higher scores indicate higher activity

    Time frame: Baseline to 12 weeks and 6 months

  11. Change in Pittsburgh Sleep Quality Index

    A self-report measure of sleep quality, higher scores indicate poorer sleep quality

    Time frame: Baseline to 12 weeks and 6 months

  12. Change in ICEpop CAPability measure for Older people (ICECAP-O)

    A measure of quality of life, higher values indicate better quality of life

    Time frame: Baseline to 12 weeks and 6 months

  13. 5-level EuroQoL 5-dimension (EQ-5D-5L) questionnaire

    A measure of quality of life, higher values indicate better quality of life

    Time frame: Baseline to 12 weeks and 6 months

  14. Change in gait speed, derived from Short Physical Performance Battery

    A measure of walking speed.

    Time frame: Baseline to 12 weeks.

  15. Changes in hemodynamics of the brain as measured by fNIRS during the N-Back Task

    A measure of brain function.

    Time frame: Baseline to 12 weeks.

  16. Changes in Feeling Scale

    Measure of affective valence

    Time frame: Baseline to 12 weeks.

  17. Changes in Exercise Enjoyment Scale

    An affective measure

    Time frame: Baseline to 12 weeks.

  18. Changes in Felt Arousal Scale

    Measure of affective activation

    Time frame: Baseline to 12 weeks

07

Study locations

1 site
  • University of British Columbia
    Vancouver, British Columbia V5Z1M9, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05036304
Lead sponsor
University of British Columbia
Responsible party
Teresa Liu-Ambrose (Professor, University of British Columbia) — Principal investigator
First posted
Sep 5, 2021
Start date
Jan 19, 2022
Primary completion
Jul 10, 2023
Completion
Nov 27, 2023
Last update
Jan 29, 2024

Study contacts

Teresa Liu-Ambrose, PhD
principal investigator · University of British Columbia
Matthew Noseworthy, BSc
principal investigator · University of British Columbia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion